Search research articles
Contact Us
Filters
Showing results (81-90 of 96) with videos related to
Page
of 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2010
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L Stott, Chia-Hsien Hsu, Dina I Tsukrov, et al.
The New England Journal of Medicine
|
June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Paul B Chapman, Axel Hauschild, Caroline Robert, et al.
The New England Journal of Medicine
|
February 24, 2012
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
Jeffrey A Sosman, Kevin B Kim, Lynn Schuchter, et al.
European Urology
|
December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo, Gerhardt Attard, Steven P Balk, et al.
Cancer Discovery
|
January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer
David T Miyamoto, Richard J Lee, Mark Kalinich, et al.
The Lancet. Oncology
|
May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Alexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma
Kerstin Trunzer, Anna C Pavlick, Lynn Schuchter, et al.
Science Translational Medicine
|
April 5, 2013
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
Emre Ozkumur, Ajay M Shah, Jordan C Ciciliano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 17, 2013
Prostate cancer, version 1.2014
James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines
James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 96) with videos related to
Sort By:
Page
of 10
Proceedings of the National Academy of Sciences of the United States of America
|
October 9, 2010
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Shannon L Stott, Chia-Hsien Hsu, Dina I Tsukrov, et al.
The New England Journal of Medicine
|
June 7, 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Paul B Chapman, Axel Hauschild, Caroline Robert, et al.
The New England Journal of Medicine
|
February 24, 2012
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib
Jeffrey A Sosman, Kevin B Kim, Lynn Schuchter, et al.
European Urology
|
December 21, 2017
Role of Androgen Receptor Variants in Prostate Cancer: Report from the 2017 Mission Androgen Receptor Variants Meeting
Jun Luo, Gerhardt Attard, Steven P Balk, et al.
Cancer Discovery
|
January 6, 2018
An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer
David T Miyamoto, Richard J Lee, Mark Kalinich, et al.
The Lancet. Oncology
|
May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis
Alexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 10, 2013
Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma
Kerstin Trunzer, Anna C Pavlick, Lynn Schuchter, et al.
Science Translational Medicine
|
April 5, 2013
Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells
Emre Ozkumur, Ajay M Shah, Jordan C Ciciliano, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 17, 2013
Prostate cancer, version 1.2014
James L Mohler, Philip W Kantoff, Andrew J Armstrong, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 8, 2012
Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines
James L Mohler, Andrew J Armstrong, Robert R Bahnson, et al.
Page
of 10